- A Case of Linear Common Blue Nevi with Gradually Appearing Satellite Lesions
-
Kim SJ, Lee JS, Koo DW
- KMID: 2539556
- Korean J Dermatol.
- 2023 Feb;61(2):152-154.
-
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Milia en Plaque on the Earlobe after Repeated Chilblain
-
Kim T, Heo YW, Lee JY, Hong SP
- KMID: 2539552
- Korean J Dermatol.
- 2023 Feb;61(2):145-146.
-
- CITED
-
- Close
- SHARE
-
- Close
- Unusual Presentation of a Solitary Cutaneous Myxoma in the External Auditory Canal
-
Hong EJ, Yoon HJ, Kim JE, Park YL, Lee S, Lee SH
- KMID: 2539555
- Korean J Dermatol.
- 2023 Feb;61(2):150-152.
-
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Pemphigus Vegetans in a Young Adult Male
-
Jeon JJ, Lee SH, Choi EH
- KMID: 2539553
- Korean J Dermatol.
- 2023 Feb;61(2):146-148.
-
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Cutaneous Focal Mucinosis on the Lip
-
Cho MK, Lee HJ
- KMID: 2539554
- Korean J Dermatol.
- 2023 Feb;61(2):149-150.
-
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Acquired Reactive Perforating Collagenosis in Patient with Inclusion Body Myositis
-
Park HU, Lee MR, Kim WJ, Lee JW, Kang JW, Lee YJ, Ro BI, Cho HK
- KMID: 2539551
- Korean J Dermatol.
- 2023 Feb;61(2):143-154.
-
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Lymphomatoid Papulosis, Type F
-
Ha DL, Bang JS, Jeong JY, Han MH, Lee SJ
- KMID: 2539549
- Korean J Dermatol.
- 2023 Feb;61(2):137-139.
Lymphomatoid papulosis (LyP) is a relatively uncommon CD30＋ lymphoproliferative disorder with a good prognosis. However, it is important to be cautious because 4%∼25% of the cases are accompanied by secondary... -
- CITED
-
- Close
- SHARE
-
- Close
- Excited Skin Syndrome after Patch Testing in a Patient with Atopic Dermatitis Treated with Dupilumab
-
Lee MY, Kim YJ, Lee WJ, Chang SE, Lee MW, Won CH
- KMID: 2539550
- Korean J Dermatol.
- 2023 Feb;61(2):140-142.
The effect of dupilumab on allergic contact dermatitis or patch testing is unknown. Here, we present a case of excited skin syndrome that appeared after patch testing during dupilumab treatment.... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Sodium Thiosulfate Solution and a Mixture of Diflucortone Valerate and Isoconazole Nitrate for Pityriasis Versicolor
-
Kim T, Kim J, Park J
- KMID: 2539546
- Korean J Dermatol.
- 2023 Feb;61(2):119-123.
Background: Skin diseases associated with Malassezia species include malassezia folliculitis, pityriasis versicolor, and seborrheic dermatitis. Although several treatment options are available for the treatment of pityriasis versicolor, there is a... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Characteristics and Antibiotic Susceptibility of Staphylococcus lugdunensis Isolated from Skin Diseases: A Retrospective Single-Center Study
-
Jang YK, Lee HJ, Kim DH, Yoon MS, Shin JU
- KMID: 2539547
- Korean J Dermatol.
- 2023 Feb;61(2):124-129.
Background: Staphylococcus lugdunensis is an emerging pathogen in skin and soft tissue infections. However, until recently, the role of S. lugdunensis as a skin pathogen remained underrated. Objective: The purpose of... -
- CITED
-
- Close
- SHARE
-
- Close
- Expression of Antioxidant Response and Autophagy Markers in Patients with Vitiligo: An Immunohistochemical Study
-
Hong EJ, Yoon HJ, Kwon R, Park YL, Lee SH, Lee S
- KMID: 2539541
- Korean J Dermatol.
- 2023 Feb;61(2):79-85.
Background: Oxidative stress is generally accepted as one of the principal pathogenesis of vitiligo, and keratinocyte-melanocyte interactions are also thought to play critical roles. It is well-known that antioxidant response... -
- CITED
-
- Close
- SHARE
-
- Close
- Skin Diseases among Patients with Type 2 Diabetes Mellitus: A Nationwide Population-Based Cohort Study
-
Lee JY, Jung SW, Jeon JJ, Lee S, Hong SP
- KMID: 2539545
- Korean J Dermatol.
- 2023 Feb;61(2):109-118.
Background: Diabetes mellitus (DM) is one of the most common endocrine diseases, and the relationship between diabetes and skin diseases is well-known and its mechanisms have been studied. Objective: This study... -
- CITED
-
- Close
- SHARE
-
- Close
- A Statistical Study of Skin Cancers in Gwangju, Chonnam Province over a 10-Year Period (2007∼2016): Comparison of Trends in 5,150 Skin Cancers Cases over 40 Years (1968∼1977, 1987∼2016) in the Same Region
-
Song J, Lee JB, Yun SJ
- KMID: 2539544
- Korean J Dermatol.
- 2023 Feb;61(2):100-108.
Background: The incidence of skin cancers has been continuously increasing in Korea. Therefore, it is important to perform repetitive statistical research investigating the distribution and incidence of skin cancers in... -
- CITED
-
- Close
- SHARE
-
- Close
- A Clinicopathological Study of Nodular Hidradenoma: Reclassification of Nodular Hidradenoma According to Ackerman’s Criteria
-
Kwon HM, Shin DH, Choi JS, Bae YK
- KMID: 2539543
- Korean J Dermatol.
- 2023 Feb;61(2):92-99.
Background: Nodular hidradenoma is a relatively common benign cutaneous neoplasm, which usually presents as solitary intradermal nodule. In Korea, an extensive study on tumors with eccrine differentiation was performed in... -
- CITED
-
- Close
- SHARE
-
- Close
- Association between Allergic Diseases and the Number of Persons per Household Using Data from the National Health and Nutrition Examination Survey
-
Yoo SA, Doh JY, Yoo EH, Kim YH, Han KD, Lee JH
- KMID: 2539548
- Korean J Dermatol.
- 2023 Feb;61(2):130-136.
Background: Atopic dermatitis (AD) and asthma are chronic allergic diseases that affect quality of life. Objective: In this study, we analyzed data from the Korea National Health and Nutrition Examination Survey... -
- CITED
-
- Close
- SHARE
-
- Close
- Real-World Experience of the Efficacy and Safety of Upadacitinib 15 mg in Patients with Atopic Dermatitis in Korea
-
Na HM, Choi EJ, Jeon SH, Chang ZF, Choi ME, Moon IJ, Jung JM, Lee WJ, Chang SE, Lee MW, Won CH
- KMID: 2539542
- Korean J Dermatol.
- 2023 Feb;61(2):86-91.
Background: Upadacitinib is an oral Janus kinase1 (JAK1)-selective inhibitor, which showed a quick and significant effect on patients with atopic dermatitis in several phase 3 clinical studies. Although, an increasing... -
- CITED
-
- Close
- SHARE
-
- Close
